Home Cart 0 Sign in  

[ CAS No. 124655-17-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 124655-17-0
Chemical Structure| 124655-17-0
Structure of 124655-17-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 124655-17-0 ]

Related Doc. of [ 124655-17-0 ]

Alternatived Products of [ 124655-17-0 ]

Product Details of [ 124655-17-0 ]

CAS No. :124655-17-0 MDL No. :MFCD00065575
Formula : C11H21NO4 Boiling Point : -
Linear Structure Formula :- InChI Key :LRFZIPCTFBPFLX-ZETCQYMHSA-N
M.W : 231.29 Pubchem ID :7005057
Synonyms :
Boc-D-tert-leucine

Calculated chemistry of [ 124655-17-0 ]

Physicochemical Properties

Num. heavy atoms : 16
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.82
Num. rotatable bonds : 6
Num. H-bond acceptors : 4.0
Num. H-bond donors : 2.0
Molar Refractivity : 61.02
TPSA : 75.63 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.09 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.26
Log Po/w (XLOGP3) : 2.28
Log Po/w (WLOGP) : 2.01
Log Po/w (MLOGP) : 1.42
Log Po/w (SILICOS-IT) : 0.75
Consensus Log Po/w : 1.74

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -2.31
Solubility : 1.12 mg/ml ; 0.00485 mol/l
Class : Soluble
Log S (Ali) : -3.51
Solubility : 0.0722 mg/ml ; 0.000312 mol/l
Class : Soluble
Log S (SILICOS-IT) : -1.47
Solubility : 7.8 mg/ml ; 0.0337 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.81

Safety of [ 124655-17-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 124655-17-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 124655-17-0 ]
  • Downstream synthetic route of [ 124655-17-0 ]

[ 124655-17-0 ] Synthesis Path-Upstream   1~8

  • 1
  • [ 26782-71-8 ]
  • [ 24424-99-5 ]
  • [ 124655-17-0 ]
YieldReaction ConditionsOperation in experiment
83% With sodium hydroxide In methanol; water at 0 - 20℃; Intermediate 95To a solution of 3-methyl-D-valine (900 mg, 6.86 mmol) in 7 mL of 1 M aqueous sodium hydroxide and 7 mL of methanol was added Boc-anhydride (1 .797 g, 8.23 mmol) at 0°C. The reaction mixture was warmed to room temperature and stirred overnight. After most of the methanol was evaporated, the solution was acidified to pH 2 with an aqueous solution of HCI (1 M) and extracted 3 times with ethylacetate (3 x 20 mL). The organic layers were combined and washed with brine (2 x 5mL). Evaporation of the solvent afforded the title compound as a white solid with a 83percent yield(1.36 g).H NMR (400 MHz, DMSO-c/6): δ ppm 12.44 (1 H, s), 6.82 (1 H, d), 3.76 (1 H, d), 1.38 (9H, (9H, s); UPLC: 0.64 min, 232 [M+H]+
1.36 g With sodium hydroxide In methanol; water at 0 - 20℃; Intermediate 76 N-[(1,1-dimethylethyl)oxy]carbonyl}-3-methyl-D-valine [0708] [0709] To a solution of 3-methyl-D-valine (900 mg, 6.86 mmol) in 7 ml of 1 M aqueous sodium hydroxide and 7 ml of methanol was added Boc-anhydride (1.797 g, 8.23 mmol) at 0° C. The reaction mixture was warmed to room temperature and stirred overnight. After most of the methanol was evaporated, the solution was acidified to pH 2 with an aqueous solution of HCl (1M) and extracted 3 times with ethylacetate (3×20 ml). The organic layers were combined and washed with brine (2×5 ml). Evaporation of the solvent afforded the title compound as a white solid (1.36 g). [0710] 1H NMR (400 MHz, DMSO-d6): δ ppm 12.44 (1H, s), 6.82 (1H, d), 3.76 (1H, d), 1.38 (9H, s), 0.93 (9H, s); UPLC: 0.64 min, 232 [M+H]+
Reference: [1] Patent: WO2011/69951, 2011, A1, . Location in patent: Page/Page column 77
[2] Journal of Medicinal Chemistry, 2008, vol. 51, # 15, p. 4620 - 4631
[3] Journal of Medicinal Chemistry, 2011, vol. 54, # 13, p. 4815 - 4830
[4] Patent: WO2012/76877, 2012, A1, . Location in patent: Page/Page column 97
[5] Patent: US2013/267510, 2013, A1, . Location in patent: Paragraph 0708-0710
  • 2
  • [ 24424-99-5 ]
  • [ 124655-17-0 ]
Reference: [1] Patent: US2013/66109, 2013, A1, . Location in patent: Paragraph 0320; 0321; 0322
  • 3
  • [ 142618-92-6 ]
  • [ 124655-17-0 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1992, vol. 40, # 4, p. 1077 - 1079
[2] Tetrahedron, 1997, vol. 53, # 4, p. 1275 - 1294
  • 4
  • [ 24424-99-5 ]
  • [ 124655-17-0 ]
Reference: [1] Tetrahedron, 1997, vol. 53, # 4, p. 1275 - 1294
[2] Tetrahedron, 1997, vol. 53, # 4, p. 1275 - 1294
  • 5
  • [ 142618-89-1 ]
  • [ 124655-17-0 ]
Reference: [1] Tetrahedron, 1997, vol. 53, # 4, p. 1275 - 1294
[2] Tetrahedron, 1997, vol. 53, # 4, p. 1275 - 1294
  • 6
  • [ 630-19-3 ]
  • [ 124655-17-0 ]
Reference: [1] Patent: US2013/66109, 2013, A1,
[2] Patent: US2013/66109, 2013, A1,
  • 7
  • [ 153960-35-1 ]
  • [ 124655-17-0 ]
Reference: [1] Tetrahedron Asymmetry, 2006, vol. 17, # 13, p. 1995 - 1999
  • 8
  • [ 330455-53-3 ]
  • [ 124655-17-0 ]
Reference: [1] Patent: US2013/66109, 2013, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 124655-17-0 ]

Amino Acid Derivatives

Chemical Structure| 13734-41-3

[ 13734-41-3 ]

Boc-Val-OH

Similarity: 0.98

Chemical Structure| 54895-12-4

[ 54895-12-4 ]

2-((tert-Butoxycarbonyl)amino)-3-methylbutanoic acid

Similarity: 0.98

Chemical Structure| 22838-58-0

[ 22838-58-0 ]

Boc-D-Val-OH

Similarity: 0.98

Chemical Structure| 176504-88-4

[ 176504-88-4 ]

(S)-Methyl 2-((tert-butoxycarbonyl)amino)-3,3-dimethylbutanoate

Similarity: 0.95

Chemical Structure| 45170-31-8

[ 45170-31-8 ]

N-(tert-Butoxycarbonyl)-N-methyl-L-valine

Similarity: 0.95